Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration
| Autor: | Christian Prünte, Xavier Cos, W. David Strain |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Vascular Endothelial Growth Factor A
medicine.medical_specialty endocrine system diseases genetic structures Endocrinology Diabetes and Metabolism Treatment outcome Diabetic macular edema Visual impairment Collaborative Care Angiogenesis Inhibitors 030209 endocrinology & metabolism Blindness Macular Edema 03 medical and health sciences 0302 clinical medicine Endocrinology Diabetes mellitus Internal Medicine Humans Medicine Cooperative Behavior Disease management (health) Intensive care medicine Macular edema Patient Care Team Diabetic Retinopathy business.industry General Medicine Diabetic retinopathy medicine.disease eye diseases Surgery Treatment Outcome Intravitreal Injections 030221 ophthalmology & optometry medicine.symptom business |
| Zdroj: | Diabetes Research and Clinical Practice. 126:1-9 |
| ISSN: | 0168-8227 |
| DOI: | 10.1016/j.diabres.2017.01.013 |
| Popis: | Diabetes is a growing worldwide epidemic and a leading cause of blindness in working-age people around the world. Diabetic retinopathy (DR) and diabetic macular edema (DME) are common causes of visual impairment in people with diabetes and often indicate the presence of diabetes-associated preclinical micro- and macrovascular complications. As such, patients with DR and DME often display complex, highly comorbid profiles. Several treatments are currently available for the treatment of DME, including anti-vascular endothelial growth factor (VEGF) agents, which are administered via intravitreal injection. While the safety profiles of approved ocular anti-VEGF therapies have been reassuring, the high-risk nature of the DME patient population means that treatment must be carefully considered and a holistic approach to disease management should be taken. This requires multidisciplinary, collaborative care involving all relevant specialties to ensure that patients not only receive prompt treatment for DME but also appropriate consideration is taken of any systemic comorbidities to evaluate and minimize potentially serious safety issues. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect